Leading Alzheimer’s Researchers Coming to Nashville for GAP-Net Site Optimization Conference

Researchers, recruiters, and CEOs from more than 70 Alzheimer’s clinical trial sites to share strategies on finding a cure for the deadly disease

From February 27 – March 1, the Global Alzheimer’s Platform Foundation (GAP), an organization dedicated to speeding and improving Alzheimer’s clinical trials in pursuit of a cure, will convene more than 150 representatives from its network (GAP?Net) of 70+ Alzheimer’s clinical research sites at the Nashville Marriott at Vanderbilt University. The conference is an opportunity for leading public, private and academic research institutes across the United States and Canada to exchange strategies on finding a cure for Alzheimer’s, which has proven elusive due to the challenge of recruiting and retaining clinical trial volunteers.

WHEN: February 27 – March 1

WHERE: Nashville Marriott at Vanderbilt University

WHO: World?class researchers, recruiters, and CEOs from GAP?Net’s 70+ clinical trial sites across the United States and Canada, including Dr. Joy Snider (Washington University), Dr. Anna Burke, (Barrow Neurological Institute), Dr. Gad Marshall (Brigham and Women’s Hospital, Harvard Medical School), Dr. Paul Newhouse (Vanderbilt University), and more.

The conference will also stress the importance of brain health through its Acti?v8 Your Brain initiative, which encourages people to prevent cognitive decline by adopting healthy lifestyle changes. Until a cure for Alzheimer’s is found, this is the best way to stave off dementia.

  • More than 120,000 Tennesseans and 5.5 million Americans over the age of 65 have Alzheimer’s, a number that is expected to increase 17% by 2025 and keep rising as the population ages. Alzheimer’s is the most feared disease by people over the age of 50 years old, but researchers still have unique challenges in recruiting and retaining volunteers in Alzheimer’s disease studies.
  • Nearly 90 percent of Alzheimer’s clinical trials are delayed because there aren’t enough volunteers.
  • GAP President John Dwyer will speak to regulatory changes in Medicare Advantage that may transform the landscape for early diagnosis and recruitment for Alzheimer’s research. Finding a cure for Alzheimer’s will require an all?hands?on?deck approach, and that includes payers as well as researchers.GAP can arrange interviews with leading researchers from across the U.S. and Canada, as well as GAP President John Dwyer and other GAP staff. They can speak to the challenges facing Alzheimer’s clinical trials and strategies to overcome them in order to find a cure.

To read the full advisory, click here.

To top